E2f As a Target for Treatment of Hormone Refractory Prostate Cancer
The instant invention provides amino acid sequences competing with E2F for DNA binding. Methods of using said amino acid sequences for treatment of hormone-refractory prostate cancer are also provided.
BERTINO JOSEPH R [US]; BANERJEE DEBABRATA [US]; MINKO TAMARA [US]; GARBUZENKO OLGA B [US]; XIE XIAOQI [US]; KERRIGAN JOHN EDWARD
Type of Offer:
« More Biotech Patents